Drug Development

Research into Cold Cancers Heating Up

Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.

Development of Gamma-Delta T-Cell Therapies

Activation and expansion are essential for success in both autologous and allogeneic therapies.

QbD for Small-Molecule Continuous Process Development

Continuous manufacturing and a quality-by-design development approach are a natural fit.

Integrated Biosciences Collaborates with Illumina Ventures Labs Collaborate on Novel Therapeutics

May 29, 2024

The partnership will create therapeutic assets and new discovery platforms and potentially reshape drug discovery.

Highlighting Personalized mRNA-Based Vaccines for Pancreatic Cancer (ASGCT 2024)

May 25, 2024

In an ASGCT Panel on nucleic acid- and cell-based vaccines in oncology, work on a personalized mRNA vaccine was highlighted.

AGC Biologics Partners with BioConnection to Offer Biopharma Drug Substance and Drug Product Development and Manufacturing

May 25, 2024

The partnership aims to provide end-to-end development and manufacturing for biopharmaceutical drug substance and drug product.

Biogen to Acquire HI-Bio in Deal Worth Potentially Up to $1.8 Billion

May 24, 2024

With the acquisition, Biogen gains felzartamab, HI-Bio's lead investigational mAb candidate being developed for the treatment of a range of immune-mediated diseases.

Webcasts

Overviews of Lyophilization Process Steps and Mechanisms for Biological Molecule Stabilization During Freezing, Drying and Storage

May 21, 2024

Webinar Date/Time: Mon, Jun 24, 2024 11:00 AM EDT

Webcasts

Lean Process Development for Continuous Tableting: Foundations of a Hybrid Approach

May 16, 2024

Webinar Date/Time: Wednesday, May 29th 11am EDT | 4pm GMT | 5pm CEST

Webcasts

Controlled Release Redefined: The Strategic Use of Excipients in Formulations

May 16, 2024

Webinar Date/Time: Wed, Jun 12, 2024 11:00 AM EDT